← Open Payments lookup

ARSHAD KHANANI: Open Payments

NPI 1295929511 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$424,127 in 228 payments from 20 companies in 2025. Trend: 2023 $285,498 · 2024 $312,929 · 2025 $424,127

Consulting: $376,281Speaker / faculty: $24,400Travel & lodging: $15,032Food & beverage: $4,314Honoraria: $4,100
CompanyPaymentsAmount
Ocular Therapeutix, Inc.90$115,232
Astellas Pharma US Inc36$107,663
F. Hoffmann-La Roche AG18$51,025
Astellas Pharma Global Development10$46,013
Genentech, Inc.6$29,836
ABBVIE INC.20$28,927
SANOFI US SERVICES INC.2$15,903
Apellis Pharmaceuticals, Inc.2$5,430
Amgen Inc.1$5,250
Genentech USA, Inc.23$4,754

Products named: Izervay, Vabysmo, OZURDEX, Lucentis, Syfovre, PAVBLU, PURIFIED CORTROPHIN GEL, Cequa.

Industry payments across NV — which companies pay providers there.